Side Effects of Brolucizumab

by Tahmineh Motevasseli, Saeed Mohammadi, Fatemeh Abdi, William R. Freeman
Published 2021

A retrospective study of the real-life utilization and effectiveness of ranibizumab therapy for neovascular age-related macular degeneration in the UK

by Hykin P, Chakravarthy U, Lotery A, McKibbin M, Napier J, Sivaprasad S
Published 2016

Anatomical and functional response after conversion to aflibercept using the treat-and-extend regimen protocol in bevacizumab treatment-resistant wet age-related macular degenerati...

by Taipale C, Laine I, Tuuminen R
Published 2018

A Multicenter, Cross-Sectional Study of the Incidence of Major Macular Diseases That Cause Visual Impairment and Require Therapeutic Intervention in Greece: The ADVICE Study

by Karagiannis DA, Lygerou M, Papadopoulos G, Kabanarou SA, Aspiotis M, Dardabounis DC, Minakakis PG, Spai SI, Koutsandrea C, Oikonomidis P, Pantelopoulou GN, Kousidou OC, Tsilimbaris M
Published 2020

Management of neovascular age-related macular degeneration: Taiwan expert consensus

by Ling Yeung, Yi-Ting Hsieh, Chang-Hao Yang, Lee-Jen Chen, Shih-Jen Chen, Cheng-Kuo Cheng, Shwu-Jiuan Sheu, Ching-Yao Tsai, Tsung-Tien Wu, Wei-Chi Wu, San-Ni Chen
Published 2021

The emotional and physical impact of wet age-related macular degeneration: findings from the wAMD Patient and Caregiver Survey

by Varano M, Eter N, Winyard S, Wittrup-Jensen KU, Navarro R, Heraghty J
Published 2016

Physician, patient, and caregiver experience of different wet age-related macular degeneration anti-VEGF treatment regimens in Japan: a qualitative assessment

by Iida T, Ishii K
Published 2016